Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Circassia Pharmaceuticals ( (GB:NIOX) ) has provided an announcement.
NIOX Group plc has launched its 2026 Save As You Earn Scheme for eligible UK employees, granting options over ordinary shares at a 20% discounted exercise price of 45.02 pence. The three-year savings plan is intended to broaden employee share ownership and align staff interests more closely with the company’s long-term performance.
In total, 99,042 options have been granted, representing about 0.02% of NIOX’s issued share capital, with 40,426 options awarded to Chief Executive Officer Jonathan Emms as a person discharging managerial responsibilities. The modest scale of the scheme limits dilution for existing shareholders while signalling continued use of equity-based incentives to retain key talent and support corporate growth objectives.
The most recent analyst rating on (GB:NIOX) stock is a Buy with a £86.00 price target. To see the full list of analyst forecasts on Circassia Pharmaceuticals stock, see the GB:NIOX Stock Forecast page.
Spark’s Take on NIOX Stock
According to Spark, TipRanks’ AI Analyst, NIOX is a Neutral.
The score is primarily supported by strong financial quality (growth, profitability, low debt, and solid cash generation). It is held back by bearish technical signals (price below major moving averages and negative MACD) and a high P/E that is only partly offset by the dividend yield.
To see Spark’s full report on NIOX stock, click here.
More about Circassia Pharmaceuticals
NIOX Group plc, listed on AIM, operates in the healthcare sector and focuses on respiratory diagnostics through its NIOX-branded products. The company targets clinicians and healthcare systems seeking non-invasive tools to support the management of conditions such as asthma and other airway inflammations.
Average Trading Volume: 755,109
Technical Sentiment Signal: Buy
Current Market Cap: £281.9M
For detailed information about NIOX stock, go to TipRanks’ Stock Analysis page.

